Resazurin Cell Viability Assay

– 25 mL Resazurin solution (ready-to-use)

• Measurement of cell viability and proliferation.

• Cytotoxicity assays for drug screening.

• Antimicrobial and antifungal testing.

• High-throughput screening of compounds.

• Toxicology and pharmacology research.

t

Each lot is tested for:

• Signal-to-noise ratio with mammalian cells.

• Consistency of fluorescence and absorbance readouts.

• Absence of contamination.

• Protect solution from light at all times.

• Mix thoroughly after thawing.

• Use RNase/DNase-free consumables to prevent interference in downstream analysis.

• Shipped in: Ambient Temperature.
• Storage: It can be stored at 4 °C in the dark for up to 12 months and at –20 °C in the dark for long term storage.
• Guaranteed: All components are stable for at least  10 freeze-thaw cycles.

• Moreno-Montilla, M. T., Pedraza-Arevalo, S., Martínez-López, A., Blázquez-Encinas, R., García-Vioque, V., Rodríguez-Ortiz, L., … & Ibáñez-Costa, A. (2025). Exploring RNA biology in Pseudomyxoma peritonei uncovers splicing dysregulation as a novel, targetable molecular vulnerability. Cancer Gene Therapy, 1-16.
• Marques-Magalhães Aˆ , Moreira-Silva F, Grac¸a I, Dias PC, Correia MP, Alzamora MA, Henrique R, Lopez M, Arimondo PB, Miranda-Gonc¸alves V and Jero´ nimo C (2025) Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma. Front. Oncol. 15:1399956
• Porcel-Pastrana, F., et.al. (2025). Cellular and Molecular Evidence of the Synergistic Antitumour Effects of Hydroxytyrosol and Metformin in Prostate Cancer. International Journal of Molecular Sciences, 26(3), 1341.
• Estaún Allué, Á. G. (2024). Análisis de la irisina, una proteína inducida por el ejercicio físico, como inhibidor de la agregación amiloide de alfa-sinucleína asociada a la enfermedad de Parkinson. Universidad de Zaragoza.
• Montero-Hidalgo, A. J., Jiménez-Vacas, J. M., Gómez-Gómez, E., Porcel-Pastrana, F., Sáez-Martínez, P., Pérez-Gómez, J. M., … & Luque, R. M. (2024). SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer. Science Advances, 10(40), eado8231.
• Sáez-Martínez, P., Porcel-Pastrana, F., Montero-Hidalgo, A. J., de la Haba, S. L., Sanchez-Sanchez, R., González-Serrano, T., … & Luque, R. M. (2024). Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1. Cancer Letters, 584, 216604.
• Kola-Mustapha, A.T.; Aliu, M.H.; Bello, R.H.; Adedeji, O.J.; Ghazali, Y.O. The Formulation and Evaluation of Melaleuca alternifolia Cheel and Cymbopogon flexuosus Linn Essential Oils Emulgel for the Treatment of Vulvovaginal Candidiasis. Gels 2023, 9, 949.
• Blázquez-Encinas, R., García-Vioque, V., Caro-Cuenca, T., Moreno-Montilla, M. T., Mangili, F., Alors-Pérez, E., … & Castaño, J. P. (2023). Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.
• Jimenez-Vacas, J. M., Montero-Hidalgo, A. J., Gomez-Gomez, E., Saez-Martinez, P., Perez-Gomez, J. M., Fuentes-Fayos, A. C., … & Luque, R. M. (2023). The splicing factor SRSF6 regulates AR activity and represents a potential therapeutic target in prostate cancer.
• Mikra, C., Mitrakas, A., Ghizzani, V., Katsani, K. R., Koffa, M., Koukourakis, M., … & Fylaktakidou, K. C. (2023). Effect of Arylazo Sulfones on DNA: Binding, Cleavage, Photocleavage, Molecular Docking Studies and Interaction with A375 Melanoma and Non-Cancer Cells. International Journal of Molecular Sciences, 24(3), 1834.
• Monteiro-Reis, S., Miranda-Gonçalves, V., Guimarães-Teixeira, C., Martins-Lima, C., Lobo, J., Montezuma, D., … & Jerónimo, C. (2023). Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition. International Journal of Biological Sciences, 19(1), 1.
• Moreira-Silva, F., Outeiro-Pinho, G., Lobo, J., Guimarães, R., Gaspar, V. M., Mano, J. F., … & Jerónimo, C. (2022). G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models. Biomedicine & Pharmacotherapy, 150, 113031.
• Schachtl-Riess, J. F., Coassin, S., Lamina, C., Demetz, E., Streiter, G., Hilbe, R., & Kronenberg, F. (2021). Lysis reagents, cell numbers, and calculation method influence high-throughput measurement of HDL-mediated cholesterol efflux capacity. Journal of Lipid Research, 100125.
• Miranda-Gonçalves, Vera, et al. “The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors.” Journal of Experimental & Clinical Cancer Research 40.1 (2021): 1-18.
• Seguí, P., Aguilera-Correa, J. J., Domínguez-Jurado, E., Sánchez-López, C. M., Pérez-Tanoira, R., Ocaña, A. V., … & Molina-Alarcón, M. (2021). A novel bis (pyrazolyl) methane compound as a potential agent against Gram-positive bacteria. Scientific Reports, 11(1), 1-10.
• Pacheco, Mariana Brütt, et al. “Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines.” Pharmaceuticals 14.7 (2021): 670.
• León-González, A. J., Sáez-Martínez, P., Jiménez-Vacas, J. M., Herrero-Aguayo, V., Hidalgo, A. J. M., Gómez-Gómez, E., … & Luque, R. M. (2020). Cytotoxic effect of hydroxytyrosol and its semisynthetic derivatives against prostate cancer cells.
• Lobo, J., Cardoso, A. R., Miranda-Gonçalves, V., Looijenga, L. H. J., Lopez, M., Arimondo, P. B., … & Jerónimo, C. (2021). Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. Pharmaceutics 2021, 13, 73.
• Lobo, J., Cardoso, A. R., Miranda-Gonçalves, V., Looijenga, L. H., Lopez, M., Arimondo, P. B., … & Jerónimo, C. (2021). Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. Pharmaceutics, 13(1), 73.
• Ženata, O., Panáček, A., Kvítek, L., & Vrzal, R. (2020). The impact of graphene oxide on androgen receptor signalling in prostate cancer cells. Chemosphere, 128759.
• Sáez Martínez, P., Jiménez-Vacas, J. M., León González, A. J., Herrero-Aguayo, V., Montero-Hidalgo, A. J., Gómez-Gómez, E., … & Luque, R. M. (2020). Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer.
• Zenata, O., Vrzalova, A., Bachleda, P., Janečková, J., Panáček, A., Kvítek, L., & Vrzal, R. (2020). The effect of graphene oxide on signalling of xenobiotic receptors involved in biotransformation. Chemosphere, 126753.
• Boch, M. E. (2018). Effect of Silk-Based Hydrogel Topography on Intestinal Epithelial Cell Morphology and Wound Healing In Vitro.
• Basso, M., Venditti, C., Raponi, G., Navazio, A. S., Alessandri, F., Giombini, E., … & Venditti, M. (2019). A case of persistent bacteraemia by Ralstonia mannitolilytica and Ralstonia pickettii in an intensive care unit. Infection and Drug Resistance, 12, 2391.

This product is developed, designed and sold exclusively for Research purposes and in vitro use only (RUO). The product was not tested for use in diagnostics or for drug development, nor is it suitable for administration to humans or animals. For more info, please check its Material Safety Data Sheet available in this website.

Resazurin viability assay, Alamar Blue assay, Cell viability assay resazurin, Metabolic activity assay, Fluorometric cell viability assay

Also known as:

• Spanish: Ensayo de viabilidad celular con resazurina, Ensayo Alamar Blue, Ensayo de actividad metabólica
• French: Test de viabilité cellulaire à la résazurine, Essai Alamar Blue, Essai d’activité métabolique
• German: Resazurin-Zellviabilitätsassay, Alamar-Blue-Test, Metabolischer Aktivitätsassay
• Italian: Saggio vitalità cellulare con resazurina, Saggio Alamar Blue, Saggio attività metabolica

Q: Is Resazurin suitable for high-throughput screening?
A: Yes, it is compatible with 96- and 384-well plate formats.

Q: Can it be used for bacteria and yeast?
A: Yes, the assay works across eukaryotic and prokaryotic systems.

Q: How does it compare to MTT?
A: Resazurin offers a safer, non-toxic, and more sensitive alternative with a simpler protocol.